Throughout his treatment in 2020, Matt continued to be your typical chemical patent examiner and would research the patents on his chemotherapy drugs and relay what he found to his oncologist, who believed one was an invention stolen from Australia.
Given his scientific research background, it's no surprise that his final wish was to support critical research required to change the current trajectory for patients living with a sarcoma diagnosis.
All raised funds will be passed to The Cooper Rice-Brading Foundation, which is currently seeking funds for the a world first IL23 sarcoma clinical study in conjunction with the Garvan Institute of Medical Research. This fund is being named in Matt’s honour.
For more information on the The Matthew Fisher Sarcoma Research Fund, please visit https://www.crbf.org.au/matthew-fisher-sarcoma-research-fund/
Fundraising team (3)
#1 fundraising platform
More people start fundraisers on GoFundMe than on any other platform. Learn more
In the rare case something isn’t right, we will work with you to determine if misuse occurred. Learn more
Expert advice, 24/7
Contact us with your questions and we’ll answer, day or night. Learn more